Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy
NCT00033813Phase 2Completed
- Sponsor
- Cooperative International Neuromuscular Research Group
- Start
- Jan 2002
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Oxatomide in Duchenne muscular dystrophy (DMD), sponsored by Cooperative International Neuromuscular Research Group. Started Jan 2002; status: completed.
02
Drugs
Oxatomide
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT00033813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033813.